- ThermoGenesis Holdings ( NASDAQ: THMO ) said Nasdaq notified the cell-based therapies company of having regained compliance with the stock exchange's minimum bid price requirement.
- Nasdaq had notified the company on Mar. 7, 2022, that its shares had failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days.
- The stock exchange determined on Jan. 9 that for the last 10 consecutive business days, from Dec. 22, 2022, to Jan. 6, the company's closing bid price has been at $1.00 per share or greater.
- THMO shares were trading ~4% down pre-market.
- Source: Press Release
For further details see:
ThermoGenesis regains compliance with Nasdaq's minimum bid price requirement